Taysha Gene Therapies Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags
TSHA Stock | USD 1.52 0.01 0.65% |
About 62% of Taysha Gene's investor base is looking to short. The analysis of the overall investor sentiment regarding Taysha Gene Therapies suggests that many traders are alarmed. The current market sentiment, together with Taysha Gene's historical and current headlines, can help investors time the market. In addition, many technical investors use Taysha Gene Therapies stock news signals to limit their universe of possible portfolio assets.
Taysha |
Taysha Gene Therapies Third Quarter 2024 Results Key Financial Results Net loss US25.5m loss...
Read at simplywall.st
Taysha Gene Fundamental Analysis
We analyze Taysha Gene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Taysha Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Taysha Gene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Taysha Gene is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Taysha Gene Therapies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taysha Gene stock to make a market-neutral strategy. Peer analysis of Taysha Gene could also be used in its relative valuation, which is a method of valuing Taysha Gene by comparing valuation metrics with similar companies.
Peers
Taysha Gene Related Equities
PRLD | Prelude Therapeutics | 7.02 | ||||
INZY | Inozyme Pharma | 6.82 | ||||
HOOK | Hookipa Pharma | 6.37 | ||||
GOSS | Gossamer Bio | 4.49 | ||||
STTK | Shattuck Labs | 3.57 | ||||
DAWN | Day One | 1.05 | ||||
GLUE | Monte Rosa | 0.36 | ||||
STOK | Stoke Therapeutics | 0.19 | ||||
AKRO | Akero Therapeutics | 0.08 | ||||
ALEC | Alector | 1.10 | ||||
LRMR | Larimar Therapeutics | 1.38 | ||||
BMEA | Biomea Fusion | 1.56 | ||||
CCCC | C4 Therapeutics | 2.94 | ||||
TERN | Terns Pharmaceuticals | 3.02 | ||||
CABA | Cabaletta Bio | 3.47 | ||||
XFOR | X4 Pharmaceuticals | 7.69 |
Complementary Tools for Taysha Stock analysis
When running Taysha Gene's price analysis, check to measure Taysha Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taysha Gene is operating at the current time. Most of Taysha Gene's value examination focuses on studying past and present price action to predict the probability of Taysha Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taysha Gene's price. Additionally, you may evaluate how the addition of Taysha Gene to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |